Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation.
Harrington AR, Armstrong EP, Nolan PE Jr, Malone DC. Stroke. 2013 Jun;44(6):1676-81. Epub 2013 Apr 2.
This site is best viewed in Microsoft Edge. Switch your browser for optimum viewing experience or get
Back to Top
© mph Bangladesh 2017